knowledge -WSS

knowledge

author：explore 2025-09-06 04:26:42 - browse：1

ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that works by blocking the novel — and very buzzworthy — protein target called TIGIT.

The tumor-shrinking activity of the company’s drug, called EOS-448, was minimal but still comparable to early study data from competing TIGIT-targeted drugs in development, including ones from Roche and Merck.

iTeos presented the EOS-448 Phase 1 study results at the annual meeting of the American Association for Cancer Research on Saturday.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： WATCH: Why do bright lights make us see spots?

WSS

Inside the rise of 'mukbang' eating videos

Xenotransplantation trials will require adjusting expectations, experts say

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Long Covid needs a new name — and a new frame

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Medical leaders decry Supreme Court decision on affirmative action

Pig kidney works a record two months in donated body

Peter Hotez and the public health issue of online harassment

Novo pauses ads for weight loss drug Wegovy amid demand

Anesthesiologist group: stop taking Ozempic before surgery

New weight loss drugs vying to be the next Wegovy or Mounjaro

Medicare details structure of new drug price negotiation program

Diverse clinical trials: Why aren’t we there yet?

Guidelines to prevent youth baseball injuries need more muscle

How housing is health care on Long Island

focus

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Mom launches Girl Scout troop for LGBTQ youth in Texas

Biden administration plans revamp of organ transplant system

How medical schools plan to diversify without affirmative action

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Reanimated hearts work just as well for transplants, study finds

entertainment

Wikipedia

leisure time

hotspot